Hi, this is one of those stocks that I've had in the bottom drawer for a while and outside my usual investment horizon.
Does anyone know if there are equivalent / comparable companies listed on the Nasdaq that would be valued predominantly based on the MAU and growth rates, possibly revenue multiples and what comparable multiples would be?
I do see a US listing becoming increasingly an option (see recent US investor relations job ad on LinkedIn). That being said, it's not an automatic win and I've seen this go poorly more often than not. The main driver would be if US investors would use a fundament change in valuation. We all know that ASX doesn't really know how to deal with high growth companies as Aussie investors prefer their dividends over growth a lot of the time.
So are there any common valuation approaches for companies of this type?
- Forums
- ASX - By Stock
- 360
- US based equivalent valuation
US based equivalent valuation
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 360 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$23.95 |
Change
0.000(0.00%) |
Mkt cap ! $4.396B |
Open | High | Low | Value | Volume |
$24.22 | $24.64 | $23.70 | $13.64M | 568.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 289 | $23.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$23.96 | 809 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 926 | 23.890 |
3 | 658 | 23.880 |
5 | 857 | 23.870 |
7 | 1343 | 23.860 |
3 | 391 | 23.850 |
Price($) | Vol. | No. |
---|---|---|
23.920 | 131 | 2 |
23.930 | 15 | 1 |
23.940 | 198 | 3 |
23.950 | 286 | 6 |
23.960 | 158 | 1 |
Last trade - 13.58pm 12/11/2024 (20 minute delay) ? |
Featured News
360 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online